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Figure 1. Before being given corticosteroid injection intralesion
Figure 2. After being given treatment
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A 51-year-old male came with thickening 
lesion in both legs since 2.5 years before 
presented. It started with small lesion and went 
larger. Before diagnosed, he was admitted 
to hospital due to unresolved headache. He 
complainted nausea, easily hungry, protrusion 
of both eyes without diplopia or diminution of 
vision, tremor, palpitation, and unintentional 
weight loss (25-30 kgs in a year). 
On examination, it was found that he was in 
thyrotoxic condition and has diffuse goiter. From 
skin examination he had raised hyperkeratotic, 
and waxy plaque like lesions over both pretibial 
region.
Laboratory examination confirm for 
thyrotoxic with presumably Graves’ disease 
with the result on Table 1.
Table 1. Laboratory examination
14/02/12 17/02/12 03/04/12 18/06/12 14/08/12 30/07/13 17/12/13
FT4 (ng/dL) 1.30 0.61 0.71 1.91 2.35 0.63
TSHs(μIU/mL) 0.008 12.285 0.011 <0.004 15.940
T3 (ng/mL) 1.52 1.30
TRAb(IU/L) >40.0 12.7
Thyroid scintigraphy showed diffused 
enlargement and increased uptake. Skin biopsy 
from the pretibial skin showed epidermis 
with vacuolar degeneration, partly spongiotic 
and hyperpigmentated, thickening basalis 
membrane, miksoid dermis and spreading 
chronic inflammatory cell in perivascular and 
periadneksal. It confirmed the diagnosis of 
myxedema hystologically.
The patient was given methimazole with 
starting dose 3x10 mg and propanolol 2x10 mg. 
Methimazole was reduce according to lab result. 
The pretibial lesion was given Triamcinolone 
acetonide injection intralesion in both legs with 
starting dose 0.5 cc (preparation 10 mg/cc) per 
day and increased according to response. The 
patient was response to 1.5 cc per leg per day. 
The patient also given Kloderma Ointment used 
twice a day. The lesion now thinning, flat, and 
turn hyperpigmentation as can be seen in figures. 
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